InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,479.78
(
0.38%
)
US TECH 100
18,592.00
(
0.40%
)
Dow Jones
40,553.29
(
-0.09%
)
Brent Oil
80.39
(
-0.24%
)
Bitcoin
69,243.90
(
2.13%
)
Post# of 252715
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Wednesday, 12/13/2006 11:50:50 AM

Wednesday, December 13, 2006 11:50:50 AM

Post# of 252715
Question re Medimmune research day/analyst presentation. Did any one see the presentation or look at the slides? I went through the slides and liked what I saw. However, one thing I noticed was that were only a couple of slides on Abegrin out of 200+ slides. I found this surprising because it is a high profile oncology product in phase II/III. Also, in Medimmune's recent press release on its oncology products, I did not see Abegrin mentioned. Not sure what significance this has--if any. Comments would be appreciated.

biophud
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up